Richard E. Uihlein - 31 Jul 2026 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: GALT
Reported as of: 31 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Aug 2026, 07:52:26 UTC
Prior SEC filing: 21 Jan 2026
Source filing: View source filing
Reporting owner signature: Jack W. Callicutt, by power of attorney

Key filing fact

Richard E. Uihlein filed Form 4 for GALECTIN THERAPEUTICS INC (GALT) on 04 Aug 2026.

Key facts

This page summarizes Richard E. Uihlein's Form 4 filing for GALECTIN THERAPEUTICS INC (GALT).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 04 Aug 2026, 07:52.

Change

Previous filing in this sequence was filed on 21 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001694903 Primary reporting owner

Uihlein Richard E

Relationship: Director, 10%+ Owner
Address: 4960 PEACHTREE INDUSTRIAL BLVD, SUITE 240, NORCROSS
Signature: Jack W. Callicutt, by power of attorney
Signature date: 04 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GALT transaction

Common Stock

Options Exercise

Transaction value
Shares: +31,825,235
Change %: +308%
Price: $3.00^*
Shares after: 42,162,911
Date: 31 Jul 2026
Ownership: Richard E. Uihlein Stock Trust

GALT transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,550,932
Change %: +6.1%
Price: $4.05^*
Shares after: 44,713,843
Date: 31 Jul 2026
Ownership: Richard E. Uihlein Stock Trust

GALT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 27,710
Date: 31 Jul 2026
Ownership: By Ed Uihlein Family Foundation
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GALT transaction Derivative

Line of Credit Convertible Notes

Options Exercise

Transaction value
Shares
Change %
Price
Shares after: 0
Date: 31 Jul 2026
Ownership: Richard E. Uihlein Stock Trust
Underlying class: Common Stock
Underlying amount: 31,825,235
Exercise price: $3.00
Footnotes: F1, F3

GALT transaction Derivative

Line of Credit Convertible Notes

Options Exercise

Transaction value
Shares
Change %
Price
Shares after: 0
Date: 31 Jul 2026
Ownership: Richard E. Uihlein Stock Trust
Underlying class: Common Stock
Underlying amount: 2,550,932
Exercise price: $4.05
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Consists of $91,000,000 in principal and $14,475,705 in accrued interest.

Footnote F2

Consists of $10,000,000 of principal and $331,275 of accrued interest.

Footnote F3

The Line of Credit Convertible Notes are exercisable upon issuance when the issuer draws on the Line of Credit. Notes were issued on December 19, 2022; March 31, 2023; June 30, 2023; December 29, 2023; March 29, 2024; June 28, 2024; September30, 2024; April 30, 2025; June 30, 2025 and December 31, 2025. There was no expiration date; however, the maturity date of all Line of Credit Convertible Notes was June 30, 2027.

Footnote F4

The reporting person is president and director of Ed Uihlein Family Foundation, a not-for-profit corporation. The reporting person has no pecuniary interest in the shares, however, he shares voting and dispositive power over the shares and, therefore, remains the beneficial owner of the shares solely for the purposes of Section 13(d) of the Securities Exchange Act of 1934.